Building on their prior experience assisting the Centers for Medicare & Medicaid Services (CMS) with efforts to expand access to mental health and substance use disorder treatment and to ensure quality of care, IBM Watson Health just beat out five other bidders to be awarded a $4M task with the Centers for Medicare and Medicaid Services for the evaluation of the Support Act Section 1003 Demonstration Project to increase substance use provider capacity.
Awardee Name: INTERNATIONAL BUSINESS MACHINES CORPORATION
Contract Duration: 60 months
Total Contract Value: $4,056,248.00
Action Obligation: $4,056,248.00
Funding Agency: CENTERS FOR MEDICARE AND MEDICAID SERVICES
Number of Bidders: 6
RFP ID: RMADA2-TORP-2020-0003
Award ID: 75FCMC20F0001
The SUPPORT Act Section 1003 was authorized by the U.S. Department of Health and Human Services to increase the capacity of Medicaid providers to deliver Substance Use Disorder (SUD) treatment and recovery services. More here.
IBM Watson Health, a major partner to Federal Agencies that has provided unbiased information, analytic tools, benchmarks, and research and evaluation services to the health care industry for more than 30 years, was recently noted on the updated list of NXT UP firms expected to experience rapid growth in the Federal sector in 2020 and for years to come.
